Clinical Trials Directory

Trials / Completed

CompletedNCT04052711

A Randomized, Controlled Study to Evaluate the Sensitizing Potential of FMX-101 in Healthy Volunteers Using a Repeat Insult Patch Test Design

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
233 (actual)
Sponsor
Vyne Therapeutics Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

A Randomized, Controlled Study to Evaluate the Sensitizing Potential of FMX-101 in Healthy Volunteers Using a Repeat Insult Patch Test Design

Conditions

Interventions

TypeNameDescription
DRUGFMX-101

Timeline

Start date
2016-09-08
Primary completion
2016-11-19
Completion
2016-12-19
First posted
2019-08-12
Last updated
2019-08-21

Regulatory

Source: ClinicalTrials.gov record NCT04052711. Inclusion in this directory is not an endorsement.

A Randomized, Controlled Study to Evaluate the Sensitizing Potential of FMX-101 in Healthy Volunteers Using a Repeat Ins (NCT04052711) · Clinical Trials Directory